Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AI In Drug Development: FDA Wants To Know How To Assure Data Integrity, Transparency, Reliability
May 11 2023
•
By
Brenda Sandburg
FDA issues discussion paper on use of artificial intelligence and machine learning in drug devleopment • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from AI
More from Advanced Technologies